 | • レポートコード：GIR-107A14930 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、胆管腫瘍のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。胆管腫瘍の種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・胆管腫瘍の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：NuCana、NeoGenomics、Novartis、GlaxoSmithKline、Southwest Oncology Group ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：医薬品、手術、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・胆管腫瘍の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・胆管腫瘍のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・胆管腫瘍のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・胆管腫瘍の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・胆管腫瘍の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Biliary Tumor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biliary Tumor size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Biliary Tumor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Biliary Tumor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mecine
Surgery
Other
Market segment by Application, can be divided into
Hospitals
Clinics
Other
Market segment by players, this report covers
NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Biliary Tumor
1.2 Classification of Biliary Tumor by Type
1.2.1 Overview: Global Biliary Tumor Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biliary Tumor Revenue Market Share by Type in 2020
1.2.3 Mecine
1.2.4 Surgery
1.2.5 Other
1.3 Global Biliary Tumor Market by Application
1.3.1 Overview: Global Biliary Tumor Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Biliary Tumor Market Size & Forecast
1.5 Global Biliary Tumor Market Size and Forecast by Region
1.5.1 Global Biliary Tumor Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biliary Tumor Market Size by Region, (2016-2021)
1.5.3 North America Biliary Tumor Market Size and Prospect (2016-2026)
1.5.4 Europe Biliary Tumor Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biliary Tumor Market Size and Prospect (2016-2026)
1.5.6 South America Biliary Tumor Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biliary Tumor Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biliary Tumor Market Drivers
1.6.2 Biliary Tumor Market Restraints
1.6.3 Biliary Tumor Trends Analysis
2 Company Profiles
2.1 NuCana
2.1.1 NuCana Details
2.1.2 NuCana Major Business
2.1.3 NuCana Biliary Tumor Product and Solutions
2.1.4 NuCana Biliary Tumor Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 NuCana Recent Developments and Future Plans
2.2 NeoGenomics
2.2.1 NeoGenomics Details
2.2.2 NeoGenomics Major Business
2.2.3 NeoGenomics Biliary Tumor Product and Solutions
2.2.4 NeoGenomics Biliary Tumor Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 NeoGenomics Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Biliary Tumor Product and Solutions
2.3.4 Novartis Biliary Tumor Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Biliary Tumor Product and Solutions
2.4.4 GlaxoSmithKline Biliary Tumor Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Southwest Oncology Group
2.5.1 Southwest Oncology Group Details
2.5.2 Southwest Oncology Group Major Business
2.5.3 Southwest Oncology Group Biliary Tumor Product and Solutions
2.5.4 Southwest Oncology Group Biliary Tumor Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Southwest Oncology Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biliary Tumor Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biliary Tumor Players Market Share
3.2.2 Top 10 Biliary Tumor Players Market Share
3.2.3 Market Competition Trend
3.3 Biliary Tumor Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biliary Tumor Revenue and Market Share by Type (2016-2021)
4.2 Global Biliary Tumor Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biliary Tumor Revenue Market Share by Application (2016-2021)
5.2 Biliary Tumor Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biliary Tumor Revenue by Type (2016-2026)
6.2 North America Biliary Tumor Revenue by Application (2016-2026)
6.3 North America Biliary Tumor Market Size by Country
6.3.1 North America Biliary Tumor Revenue by Country (2016-2026)
6.3.2 United States Biliary Tumor Market Size and Forecast (2016-2026)
6.3.3 Canada Biliary Tumor Market Size and Forecast (2016-2026)
6.3.4 Mexico Biliary Tumor Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biliary Tumor Revenue by Type (2016-2026)
7.2 Europe Biliary Tumor Revenue by Application (2016-2026)
7.3 Europe Biliary Tumor Market Size by Country
7.3.1 Europe Biliary Tumor Revenue by Country (2016-2026)
7.3.2 Germany Biliary Tumor Market Size and Forecast (2016-2026)
7.3.3 France Biliary Tumor Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biliary Tumor Market Size and Forecast (2016-2026)
7.3.5 Russia Biliary Tumor Market Size and Forecast (2016-2026)
7.3.6 Italy Biliary Tumor Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biliary Tumor Revenue by Type (2016-2026)
8.2 Asia-Pacific Biliary Tumor Revenue by Application (2016-2026)
8.3 Asia-Pacific Biliary Tumor Market Size by Region
8.3.1 Asia-Pacific Biliary Tumor Revenue by Region (2016-2026)
8.3.2 China Biliary Tumor Market Size and Forecast (2016-2026)
8.3.3 Japan Biliary Tumor Market Size and Forecast (2016-2026)
8.3.4 South Korea Biliary Tumor Market Size and Forecast (2016-2026)
8.3.5 India Biliary Tumor Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biliary Tumor Market Size and Forecast (2016-2026)
8.3.7 Australia Biliary Tumor Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biliary Tumor Revenue by Type (2016-2026)
9.2 South America Biliary Tumor Revenue by Application (2016-2026)
9.3 South America Biliary Tumor Market Size by Country
9.3.1 South America Biliary Tumor Revenue by Country (2016-2026)
9.3.2 Brazil Biliary Tumor Market Size and Forecast (2016-2026)
9.3.3 Argentina Biliary Tumor Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biliary Tumor Revenue by Type (2016-2026)
10.2 Middle East & Africa Biliary Tumor Revenue by Application (2016-2026)
10.3 Middle East & Africa Biliary Tumor Market Size by Country
10.3.1 Middle East & Africa Biliary Tumor Revenue by Country (2016-2026)
10.3.2 Turkey Biliary Tumor Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biliary Tumor Market Size and Forecast (2016-2026)
10.3.4 UAE Biliary Tumor Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Biliary Tumor Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biliary Tumor Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biliary Tumor Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biliary Tumor Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biliary Tumor Revenue Market Share by Region (2021-2026)
Table 6. NuCana Corporate Information, Head Office, and Major Competitors
Table 7. NuCana Major Business
Table 8. NuCana Biliary Tumor Product and Solutions
Table 9. NuCana Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. NeoGenomics Corporate Information, Head Office, and Major Competitors
Table 11. NeoGenomics Major Business
Table 12. NeoGenomics Biliary Tumor Product and Solutions
Table 13. NeoGenomics Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Biliary Tumor Product and Solutions
Table 17. Novartis Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Biliary Tumor Product and Solutions
Table 21. GlaxoSmithKline Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Southwest Oncology Group Corporate Information, Head Office, and Major Competitors
Table 23. Southwest Oncology Group Major Business
Table 24. Southwest Oncology Group Biliary Tumor Product and Solutions
Table 25. Southwest Oncology Group Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Biliary Tumor Revenue (USD Million) by Players (2019-2021)
Table 27. Global Biliary Tumor Revenue Share by Players (2019-2021)
Table 28. Breakdown of Biliary Tumor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Biliary Tumor Players Head Office, Products and Services Provided
Table 30. Biliary Tumor Mergers & Acquisitions in the Past Five Years
Table 31. Biliary Tumor New Entrants and Expansion Plans
Table 32. Global Biliary Tumor Revenue (USD Million) by Type (2016-2021)
Table 33. Global Biliary Tumor Revenue Share by Type (2016-2021)
Table 34. Global Biliary Tumor Revenue Forecast by Type (2021-2026)
Table 35. Global Biliary Tumor Revenue by Application (2016-2021)
Table 36. Global Biliary Tumor Revenue Forecast by Application (2021-2026)
Table 37. North America Biliary Tumor Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Biliary Tumor Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Biliary Tumor Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Biliary Tumor Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Biliary Tumor Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Biliary Tumor Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Biliary Tumor Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Biliary Tumor Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Biliary Tumor Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Biliary Tumor Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Biliary Tumor Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Biliary Tumor Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Biliary Tumor Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Biliary Tumor Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Biliary Tumor Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Biliary Tumor Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Biliary Tumor Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Biliary Tumor Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Biliary Tumor Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Biliary Tumor Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Biliary Tumor Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Biliary Tumor Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Biliary Tumor Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Biliary Tumor Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Biliary Tumor Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Biliary Tumor Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Biliary Tumor Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Biliary Tumor Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Biliary Tumor Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Biliary Tumor Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biliary Tumor Picture
Figure 2. Global Biliary Tumor Revenue Market Share by Type in 2020
Figure 3. Mecine
Figure 4. Surgery
Figure 5. Other
Figure 6. Biliary Tumor Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Biliary Tumor Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Biliary Tumor Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Biliary Tumor Revenue Market Share by Region (2016-2026)
Figure 13. Global Biliary Tumor Revenue Market Share by Region in 2020
Figure 14. North America Biliary Tumor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Biliary Tumor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Biliary Tumor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Biliary Tumor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Biliary Tumor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Biliary Tumor Market Drivers
Figure 20. Biliary Tumor Market Restraints
Figure 21. Biliary Tumor Market Trends
Figure 22. NuCana Recent Developments and Future Plans
Figure 23. NeoGenomics Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. Southwest Oncology Group Recent Developments and Future Plans
Figure 27. Global Biliary Tumor Revenue Share by Players in 2020
Figure 28. Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Biliary Tumor Revenue Market Share in 2020
Figure 30. Global Top 10 Players Biliary Tumor Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Biliary Tumor Revenue Share by Type in 2020
Figure 33. Global Biliary Tumor Market Share Forecast by Type (2021-2026)
Figure 34. Global Biliary Tumor Revenue Share by Application in 2020
Figure 35. Global Biliary Tumor Market Share Forecast by Application (2021-2026)
Figure 36. North America Biliary Tumor Sales Market Share by Type (2016-2026)
Figure 37. North America Biliary Tumor Sales Market Share by Application (2016-2026)
Figure 38. North America Biliary Tumor Revenue Market Share by Country (2016-2026)
Figure 39. United States Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Biliary Tumor Sales Market Share by Type (2016-2026)
Figure 43. Europe Biliary Tumor Sales Market Share by Application (2016-2026)
Figure 44. Europe Biliary Tumor Revenue Market Share by Country (2016-2026)
Figure 45. Germany Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Biliary Tumor Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Biliary Tumor Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Biliary Tumor Revenue Market Share by Region (2016-2026)
Figure 53. China Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Biliary Tumor Sales Market Share by Type (2016-2026)
Figure 60. South America Biliary Tumor Sales Market Share by Application (2016-2026)
Figure 61. South America Biliary Tumor Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Biliary Tumor Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Biliary Tumor Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Biliary Tumor Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Biliary Tumor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
世界の胆道閉鎖症治療市場 2021：企業別、地域別、種類・用途別 The Biliary Atresia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の原発性胆汁性胆管炎治療市場 2021：企業別、地域別、種類・用途別 The Primary Biliary Cholangitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の胆道障害治療市場 2021：企業別、地域別、種類・用途別 The Biliary Tract Disorder Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の腫瘍液体生検市場 2021：企業別、地域別、種類・用途別 The Liquid Tumor Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の腫瘍特異的抗原市場 2021：企業別、地域別、種類・用途別 The Tumor-Specific Antigen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…